Open original FDA record ↗Recall record
- FDA identifier
- Z-0347-2012
- Company in FDA record
- Nanotherapeutics, Inc
- FDA classification date
- Dec 2, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
On 03/10/2011 Nanotherapeutics Inc, Alachua, FL initiated a recall of their Origen DBM with Bioactive Glass Catalog # 22-2002 (2cc), 22-2005 (5cc) and 22-2010 (10cc). The same product is also distributed as NanoFUSE DBM Catalog # NAN109-02 (2cc) NAN109-05 (5cc) and NAN109-10(10cc). The products were manufactured without an approved 510k. Direct accounts were notified of the recall on 04/08/2011
Source facts
- Action
- Nanotherapeutics sent an Urgent: Medical Device Recall letter dated April 12, 2011, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to remove any unimplanted/unsold product shipped to them. Customers were asked to notify their customers and instruct them to make notification until the end user (hospital/physician) is reached. Recall Instructions: Immediately examine inventory and quarantine product subject to recall. Return all quarantined product subject to recall to: Nanotherapeutics, Inc. Attn: Receiving Department 13859 Progress Blvd, Suite 300 Alachua, Florida 32615 For questions call 386-462-9663
- Initiated
- 2011-03-10
- Root cause
- No Marketing Application
- Terminated
- 2012-04-03
- Distribution
- Nationwide Distribuiton including TX, FL, AZ, CA, NY, and MA.
- Recall number
- Z-0347-2012
- Recall status
- Terminated
- CDRH record ID
- 105049
- FDA classified
- 2011-12-02
- Recall event number
- 60335